Bio-Rad Laboratories, Inc. Class A Common Stock vs Unilever plc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.02B), while Unilever plc trades at $60.44 (market cap $130.28B). The key difference: Unilever plc is far larger — about 16.2× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Unilever plc pays a 3.71% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | UL | |
|---|---|---|
Market Cap | $8.02B | $130.28B |
Sector | Health | Consumer Staples |
52-Week High | $339.75 | $74.59 |
52-Week Low | $241.71 | $55.05 |
Enterprise Value | $7.84B | $155.73B |
Dividend Yield | — | 3.71% |
Trailing returns across standard periods
Latest headlines on both assets
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →